The U.S. imports more pharmaceutical products from Ireland than from any other country -- nearly $50 billion last year. It won't be surprising if the Trump administration especially targets those ...

Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on tariffs on the industry. Trump's Department of Commerce is looking into ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Ireland has become a major base for US pharma companies, including Pfizer, Eli Lilly and Johnson & Johnson. That’s bolstered the economies of individual towns and played a role in the country’s ...

Eli Lilly CEO Dave Ricks urged the Trump administration to move fast on ... on tariffs or retaliatory tariffs would have a negative impact on not just Lilly but the entire pharmaceutical industry.

One of the more interesting aspects about President Donald Trump's recent tariffs is that ... one of the best pharma stocks to own has been Eli Lilly (NYSE: LLY). But now, an investment in Lilly ...

Big move on Thursday as investors in Eli Lilly and ... seen whether the Trump administration might institute measures to lower the pricing power of NVO and LLY just when Lilly has the potential ...

Eli Lilly Downplays CVS Move to Drop ... according to LSEG data. Lilly also said current tariffs imposed by the Trump administration would not materially affect its forecast for 2025.

Johnson & Johnson factored roughly $400 million into its 2025 guidance to account for the impact ... the Trump administration could unleash an even bigger threat than tariffs to AbbVie, Lilly ...

President Trump recently warned big drugmakers that ... the president warned that a "tariff wall" is coming. Although AbbVie, Eli Lilly, and Johnson & Johnson manufacture many of their products ...